Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

Eligibility Criteria

• 1. Healthy female and male subjects between 18 to 75 years of age with Fitzpatrick Skin Type I - VI.
• 2. Willing to receive Profound Matrix treatments with any of the following applicators: Sublime, Sublative RF, and/or Matrix Pro applicator
• 3. Able and willing to comply with the treatment/follow-up schedule and comply with all study (protocol) requirements.
• 4. Willing to provide signed, informed consent to participate in the study
• 5. Willing to have photographs and images taken of the treated areas to be used in evaluations, publications, presentations, and marketing materials (Subject identity will be masked).
• 1. Pregnant or planning to become pregnant, having given birth less than 3 months prior to enrollment into the study, and/or breast feeding
• 2. Pacemaker or internal defibrillator or any active electrical implant anywhere in the body
• 3. Superficial metal or other implants in the treatment area, except superficial dental implants, unless these implants can be removed or covered with rolled gauze during treatment
• 4. Skin cancer in the treatment area or history of melanoma
• 5. History of current cancer and subject has undergone chemotherapy within the last 12 months
• 6. Severe concurrent conditions, such as cardiac disorders
• 7. Impaired immune system or use of immunosuppressive medications
• 8. Herpes Simplex Virus (HSV) in the intended treatment area unless treated following a prophylactic regimen
• 9. Poorly controlled endocrine disorders such as poorly controlled diabetes
• 10. Active skin condition in the treatment area such as skin infection, sores, psoriasis, eczema, rash, or open wounds
• 11. History of abnormal wound healing, keloid, or hypertrophic scar formation, as well as very thin or fragile skin
• 12. History of collagen vascular disease or vasculitic disorders
• 13. Known allergy to medication to be used during treatments such as allergy to topical anesthetic (e.g. lidocaine)
• 14. History of systemic corticosteroid therapy in past six months
• 15. Tattoos or permanent makeup in the intended treatment area
• 16. Excessively tanned skin
• 17. Facelift in the last 12 months
• 18. Aesthetics treatments/procedures (e.g. facial resurfacing and deep chemical peeling) within the last 4 months within the intended treatment area
• 19. Neuromodulator injections (e.g. Botox®), collagen, non-permanent dermal filler, or fat injections or other methods of augmentation with injected bio-material in the treated area within the last 3 months
• 20. Permanent synthetic fillers (e.g. silicone) in the treatment area
• 21. Absorbable facial threads within the last 1 year or non-absorbable facial threads within the intended treatment area
• 22. In the opinion of the Investigator, the subject is unwilling or unable to adhere to the study requirements or is otherwise unsuitable for the study